For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251223:nRSW5639Ma&default-theme=true
RNS Number : 5639M Animalcare Group PLC 23 December 2025
23 December 2025
ANIMALCARE GROUP PLC
("Animalcare" or the "Company")
Grant of options and PDMR Dealing
Animalcare Group plc (AIM: ANCR), the international animal health business,
announces that, on 22 December 2025, nil-cost options over a total of 294,222
ordinary shares with a nominal value of 20p per share ("the Options") were
awarded to Executive Directors and PDMRs of Animalcare under the Company's
Long Term Incentive Plan ("LTIP"). These are the only award of Options made to
Executive Directors under the LTIP during the 2025 financial year.
The awards will vest on the third anniversary of award (22 December 2028)
following the assessment of performance criteria based on Earnings Per Share
(EPS) growth per annum and Total Shareholder Return (TSR) over the three-year
financial period ending 31 December 2027. The use of EPS and TSR as
performance metrics and the associated performance scale is unchanged from the
most recent awards that were made in April 2024 for the three-year period
ending 31 December 2026. Performance conditions for the Options are as
follows:
3-year Earnings Per Share growth per annum Extent to which EPS tranche will vest
Less than 3% 0%
3% 25%
10% 100%
Between 3% and 10% Between 25% and 100% on a straight-line basis
Rank of the Company's TSR compared to the Comparator Group Extent to which the TSR tranche will vest
Upper quartile or above 100%
Between median and upper quartile Pro rata between 25% and 100% on a ranking basis
Median 25%
Below median 0%
50% of the Option award will be subject to the EPS performance condition and
the remaining 50% will be subject to the TSR performance condition.
Accordingly, if one of the performance conditions is met but the other is not,
the Option award will only vest in part.
After the grant of the Options, the PDMRs set out below hold the following
Options and ordinary shares:
PDMR Options Awarded Total Options Ordinary Shares
Jennifer Winter 219,296 633,044 100,650
Chris Brewster 74,926 244,503 283,513
From the 2026 financial year and beyond we expect to make any option grants
earlier in the year, usually in May following our annual Preliminary full year
results announcement.
The notification in respect of the Option Awards set out in the Annex below
was made subject to the requirements of Article 19 of the UK Market Abuse
Regulation:
ANNEX
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Jennifer Winter
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification Initial Notification
/Amendment
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Animalcare Group plc
b) LEI 213800A7XPQ528RMCC72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options in respect of the Company's Long Term Incentive Plan ("LTIP") over
ordinary shares of 20p each
b) Identification code GB0032350695
c) Nature of the transaction(s) Award of options
d) Price(s) and volume(s) Volume(s): Nil cost options over 219,296 shares
Price: Nil
e) Aggregated information N/A
- Aggregated volume
- Price
f) Date of the transaction 22 December 2025
g) Place of the transaction Outside a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Chris Brewster
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification Initial Notification
/Amendment
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Animalcare Group plc
b) LEI 213800A7XPQ528RMCC72
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Options in respect of the Company's Long Term Incentive Plan ("LTIP") over
ordinary shares of 20p each
b) Identification code GB0032350695
Award of options
c) Nature of the transaction(s)
d) Price(s) and volume(s) Volume(s): Nil-cost options over 74,926 shares
Price: Nil
e) Aggregated information N/A
- Aggregated volume
- Price
f) Date of the transaction 22 December 2025
g) Place of the transaction Outside a trading venue
Enquiries:
Animalcare Group Plc
Jennifer Winter, Chief Executive Officer +44 (0)1904 487 687
Chris Brewster, Chief Financial Officer
Media/ investor relations communications@animalcaregroup.com
Stifel Nicolaus Europe Limited +44 (0)20 7710 7600
(Nominated Adviser & Joint Broker)
Ben Maddison
Francis North
Jason Grossman
Panmure Liberum +44 (0)20 7886 2500
(Joint Broker)
Corporate Finance
Freddy Crossley/Emma Earl
Corporate Banking
Rupert Dearden
Alma Strategic +44 (0)20 3405 0205
Communications
animalcare@almastrategic.com
Caroline
Forde
Kinvara Verdon
Rose Docherty
About Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and
marketing organisation. Animalcare operates in seven European countries as
well as Australia, New Zealand and the UAE and exports to approximately 40
countries in Europe and worldwide. The Group is focused on bringing new and
innovative products to market through its own development pipeline,
partnerships and via acquisition.
For more information about Animalcare, please visit www.animalcaregroup.com
(http://www.animalcaregroup.com/) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFEAEFEEISESE
Copyright 2019 Regulatory News Service, all rights reserved